Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: YOAV KEDAR who wrote (1)	12/20/1996 6:56:00 AM
From: trevor john wilkinson	Respond to of 1906

To Yoav, Nothing specific at the moment Yoav. I will be in touch in the future. I would say Yoav that at the moment some specific US stocks are far closer to profitability(and profitable in some cases) and are far more interesting than british biotechs at this time. Watch this space(or uk and european thread). Best regards. Trevor.

To: YOAV KEDAR who wrote (1)	1/6/1997 8:20:00 PM
From: Lana M. Hinton	Respond to of 1906

I have been holding Amgen for 2 or 3 years now, and I really believe in the company. I wonder, though, why the investor opinion seems to have slacked off just a bit. Is it perhaps because of the slowing growth of Nupogen and Epogen, or is it lack of confidence in the R & D ? I was very suprised not to see Amgen listed on the top biotech picks for 97 on Silicon Investor. Does anyone have any recent info on the drug for Parkinson's Disease, and how the trials are progressing? Thank you in advance. Lana H.